Kaplan-Meier survival analysis demonstrated that high expression of HELLS, PROM2, CA9, MUC1, NQO1, and SRC was significantly associated with a poor prognosis in PAAD patients (Supplementary Figure S7). The gene discussed is PROM2; the disease is pancreatic adenocarcinoma.